Early results from Grigsons team suggest that a related drug, liraglutide, reduces opioid cravings in people with opioid use disorder ( SN: 2/17/24 )
It plans to submit the results to the Food and Drug Administration sometime mid-year.
Comparison of the decrease in glycated hemoglobin levels of diabetic patients caused by a 40-week treatment with tirzepatide (5, 10 or 15 mg/wk) or semaglutide (1 mg/wk)
Abstract Purpose This study aimed to develop a novel semaglutide-loaded dry powder inhaler (DPI) with improved bioavailability compared with oral administration while avoiding discomfort associated with injection
Factors such as temperature, pH, oxygen, light, and metal ions can significantly accelerate this oxidation process
This seems straightforward and it is, until it is not